[At issue: vascular spasms. Calmodulin antagonism to intracellular calcium].
Rüegg
J C
JC
D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002147:Calmodulin / Q000037:antagonists & inhibitors*; D003329:Coronary Vasospasm / Q000188:drug therapy*; D005275:Fendiline / Q000627:therapeutic use; D006801:Humans
D002121:Calcium Channel Blockers; D002147:Calmodulin; D005275:Fendiline
Im Visier: Gefässspasmen. Kalmodulin-Antagonismus kontra intrazelluläres Kalzium.